Technical Analysis for SNBP - Sun Biopharma Inc.

Grade Last Price % Change Price Change
grade A 5.25 0.00% 0.0000
SNBP closed unchanged on Tuesday, August 20, 2019, on 56 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical SNBP trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Slingshot Bullish Bullish Swing Setup 4.79%
Narrow Range Bar Range Contraction 4.79%
Wide Bands Range Expansion 4.79%

Older signals for SNBP ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Sun BioPharma, Inc., formerly Cimarron Medical, Inc., is a clinical stage drug development company. The Company is a biopharmaceutical company focused on developing therapies for pancreatic diseases. It is engaged in the commercial development of a polyamine analogue for pancreatic cancer and for a second indication in chronic pancreatitis. The Company's products include SBP-101, SBP-102 and SBP-103. Its SBP-101 is a polyamine compound and exhibits specificity for the exocrine pancreas, with therapeutic potential for both pancreatic cancer and pancreatitis indications. It develops SBP-101 for the treatment of patients with pancreatic ductal adenocarcinoma. The SBP-102 product is in non-clinical feasibility evaluation for the treatment of patients with pancreatitis. The SBP-103 product is in non-clinical exploratory evaluation. The Company has enrolled first patient in its Phase I clinical trial of SBP-101 in patients with previously treated pancreatic cancer.
Medicine RTT Biopharmaceutical Drug Development Gastroenterology Medical Emergencies Pancreatic Cancer Chronic Pancreatitis
Is SNBP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 16.0
52 Week Low 0.57
Average Volume 895
200-Day Moving Average 4.6184
50-Day Moving Average 3.2753
20-Day Moving Average 4.3543
10-Day Moving Average 5.1385
Average True Range 0.2344
ADX 37.05
+DI 58.6987
-DI 21.1446
Chandelier Exit (Long, 3 ATRs ) 4.5468
Chandelier Exit (Short, 3 ATRs ) 2.9532
Upper Bollinger Band 6.3908
Lower Bollinger Band 2.3178
Percent B (%b) 0.72
BandWidth 93.539719
MACD Line 0.6372
MACD Signal Line 0.607
MACD Histogram 0.0302
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.2500
Resistance 3 (R3) 5.2500 5.2500 5.2500
Resistance 2 (R2) 5.2500 5.2500 5.2500 5.2500
Resistance 1 (R1) 5.2500 5.2500 5.2500 5.2500 5.2500
Pivot Point 5.2500 5.2500 5.2500 5.2500 5.2500
Support 1 (S1) 5.2500 5.2500 5.2500 5.2500 5.2500
Support 2 (S2) 5.2500 5.2500 5.2500 5.2500
Support 3 (S3) 5.2500 5.2500 5.2500
Support 4 (S4) 5.2500